Ventria Bioscience Competitors and Similar CompaniesClear all

Ventria Bioscience's competitors and similar companies include Travere Therapeutics and GBT (Global Blood Therapeutics).
Ventria Bioscience
Ventria Bioscience
Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
Travere Therapeutics
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Founding Date
Founding Date
1993
Founding Date
2011
Founding Date
2012
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Junction City, US HQ
Aurora, US
Locations
San Diego, US HQ
Dublin, IE
Locations
South San Francisco, US HQ
Paris, FR
Berlin, DE
Baar, CH
London, GB
Employees
Employees
244% decrease
Employees
46293% increase
Employees
352106% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.4 b
Valuation ($)
4.4 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$490.7m (FY, 2025)
Revenue (est.)
$194.7m (FY, 2021)
Cost of goods
Cost of goods
N/A
Cost of goods
$10.3m (FY, 2025)
Cost of goods
$3.3m (FY, 2021)
Net income
Net income
N/A
Net income
($25.5m) (FY, 2025)
Net income
($303.1m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 7.7m
Total funding raised
$ 25m
Total funding raised
$ 88.7m
For sources of this data, please see the company profile

View Company Profiles

Travere Therapeutics
HQ
San Diego, US
Employees
462

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company